Reasonable application of  5aminosalicylic acid in inflammatory bowel  disease treatment

doi:10.3969/j.issn.1004-583X.2016.08.003

Clinical Focus

Previous Articles Next Articles

Reasonable application of 5aminosalicylic acid in inflammatory bowel disease treatment

Department of Gastroenterology， the Second Hospital of Hebei Medical University;
Hebei Key Laboratory of Gastroenterology; Hebei Institute of Gastroenterology， Shijiazhuang 050000，China

Online:2016-08-05 Published:2016-07-30
Contact: Corresponding author: Zhang Xiaolan，Email: xiaolanzh@126.com

Abstract

Abstract: 5-aminosalicylic acid (5-ASA) is the earliest medication widely used for inflammatory bowel disease (IBD) treatment with little side effect. However， improper use of drugs often appear in clinic. The present article mainly introduced the development history， therapeutic mechanism，reasonable application and side effect of 5-ASA in IBD treatment as well as its chemopreventive effect on IBDassociated colonic cancer with the purpose of 5-ASA beneficial use.

Key words: inflammatory bowel disease, colorectal neoplasms ；5-aminosalicylic acid, treatment

Guo Jinbo，Zhang Xiaolan. Reasonable application of 5aminosalicylic acid in inflammatory bowel disease treatment[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.08.003.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.08.003

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I8/820

[1]	Chen Xiaotian, Huo Lijuan. Meta-analysis of clinical significance of serum total bilirubin level in inflammatory bowel disease [J]. Clinical Focus, 2023, 38(8): 677-685.
[2]	Chen Congshui, Li Yuan, Chen Shufang. Concerning the diagnosis and integrated Chinese and Western medicine treatment of acute biliary pancreatitis in children: A case report [J]. Clinical Focus, 2023, 38(8): 726-730.
[3]	Wang Siyuan, Wang Li, Wen Xinran, Li Xiaoqing. Multisystem inflammatory syndrome in children after severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection: Two cases report and literature review [J]. Clinical Focus, 2023, 38(12): 1112-1116.
[4]	Luo Weigang, Xu Yuzhu, Zhang Lingyan, Wu Xiangyun, Bu Wei, Ren Huiling. Predictive value of the platelet function PFA-200 P2Y on the secondary prevention of acute ischemic stroke with clopidogrel [J]. Clinical Focus, 2023, 38(11): 979-983.
[5]	Wu Haotian, Fan Yuwen, Zhang Xiaolan. Guidelines for Diagnosis and Treatment of Chronic Gastritis in China (2022, Shanghai): An interpretation [J]. Clinical Focus, 2023, 38(10): 926-930.
[6]	Wang Xiaoqing, Guo Yijia, Tang Yifang, Tang Qin, Yang Jie. The efficacy and safety of different blood pressure target on secondary stroke prevention: A systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(3): 197-203.
[7]	Yu Xin, Liu Zhongyang. Predictive value of lung ultrasonography on adjusted therapeutic regimen for patients with pneumonia [J]. Clinical Focus, 2022, 37(2): 133-136.
[8]	Liu Lifang, Wang Xiaotong, Li Zhuo, Yang Ru, Liu Hua. Clinical analysis of 13 cases of brucellosis spondylitis [J]. Clinical Focus, 2022, 37(11): 1021-1024.
[9]	Song Yiran, Liang Xiaonan, Li Chenyang, Zhang Xiaolan. Interpretation on Chinese Expert Consensus of Irritable Bowel Syndrome in 2020 [J]. Clinical Focus, 2021, 36(7): 628-631.
[10]	Yin Yuanyuan, Ren Huiling. Retrospective analysis of of thrombotic antiphospholipid syndrome: in 7 cases [J]. Clinical Focus, 2021, 36(12): 1123-1127.
[11]	Fu Haixia. Study on standardized diagnosis and treatment of primary immune thrombocytopenia [J]. Clinical Focus, 2021, 36(10): 896-900.
[12]	Cao Xinxin. Diagnosis and treatment of adult Langerhans cell histiocytosis [J]. Clinical Focus, 2021, 36(10): 905-909.
[13]	Zhang Yan, Liu Yang. One case of neonatal chylothorax and literature review [J]. Clinical Focus, 2020, 35(7): 643-646.
[14]	Zhu Taiqinga, Zhang Lifenga, Yuan Xueqiana, Wang Guowenb. Three cases of nummular headache with chiair type Ⅰ malformation and literature analysis [J]. Clinical Focus, 2020, 35(6): 552-554.
[15]	Pan Haiyan, Qian Jing, Pan Min, Yu Xiaohong. Shortterm efficacy of ivabradine in patients with acute decompensated heart failure with reduced ejection fraction [J]. Clinical Focus, 2020, 35(4): 317-321.

Reasonable application of 5aminosalicylic acid in inflammatory bowel disease treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments